Life Sciences: IP/Patent Litigation
UK-wide
16 years ranked
Provided by Kirkland & Ellis International LLP
Nicola Dagg is a partner in the IP litigation team in the London office. Nicola’s practice spans four areas: (1) strategic life sciences patent and product lifecycle advice; (2) patent litigation; (3) co-ordinating global IP enforcement/defence cases; and (4) standard essential patent (SEP) and FRAND disputes. Nicola has tried over 20 cases.
Nicola has extensive experience in pharmaceutical and biologics patent litigation including blockbuster small molecule litigation against generic companies, biologics and biosimilar litigation, antibodies, immunotherapies, genetics, vaccines, diagnostics and gene therapies. Nicola also acts in market leading SEP essentiality, validity and global FRAND adjudication litigation in the tech sector. Having served as UK and European/global co-ordinating counsel for numerous strategic IP litigation cases and drawing on more than 24 years of legal, IP, life sciences and tech experience she helps clients solve their most pressing global challenges.
2018 to present Kirkland & Ellis International LLP; 2006-2018 Allen & Overy LLP; 1996-2006 Hogan Lovells
Provided by Chambers
Provided by Chambers
Nicola is a fantastic leader, innovator and disruptor. She gets results and is a great fighter.
Nicola is excellent; a force of nature.
Nicola brings a wealth of experience in this field, and her strategic insights have been instrumental in our litigation matters.
Nicola is elite in all phases. Not only is she a great litigator and strategist, she is wonderful to work with. She is always thinking of how to assist the team and the business.
Nicola Dagg is terrific in her sense of what courts will do and her thorough knowledge of related cases.
Nicola Dagg runs a very tight ship and she is very good at dealing with things from a holistic perspective; she will support you in court and boardroom. Very hands-on and very impressive.
Chambers is the leading data and intelligence partner for the legal sector.